# Dapivirine Gel Rectal Safety and PK Study

> **NCT03044379** · PHASE1 · WITHDRAWN · sponsor: **International Partnership for Microbicides, Inc.**

## Conditions studied

- HIV 1 Infection

## Interventions

- **DRUG:** Dapivirine gel (0.05%)
- **OTHER:** Universal HEC placebo gel

## Key facts

- **NCT ID:** NCT03044379
- **Lead sponsor:** International Partnership for Microbicides, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-09-29
- **Primary completion:** 2017-09
- **Final completion:** 2017-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Current program is on hold, not for safety reason
- **Last updated:** 2017-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03044379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03044379, "Dapivirine Gel Rectal Safety and PK Study". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT03044379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*